PMC:7160614 / 26703-27990
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 344 | 253-261 | Species | denotes | patients | Tax:9606 |
| 345 | 772-780 | Species | denotes | patients | Tax:9606 |
| 346 | 1278-1286 | Species | denotes | patients | Tax:9606 |
| 347 | 267-275 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 348 | 276-285 | Disease | denotes | infection | MESH:D007239 |
| 349 | 661-669 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 350 | 786-794 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 351 | 795-804 | Disease | denotes | infection | MESH:D007239 |
| 352 | 1089-1100 | Disease | denotes | lymphopenia | MESH:D008231 |
| 353 | 1228-1239 | Disease | denotes | lymphopenia | MESH:D008231 |
| 354 | 1252-1260 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 355 | 1269-1277 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T61 | 192-196 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
| T62 | 506-511 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
| T63 | 587-591 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
| T64 | 641-645 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
| T65 | 921-925 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T48 | 192-196 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
| T49 | 587-591 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
| T50 | 641-645 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
| T51 | 921-925 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T105 | 267-275 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T106 | 276-285 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T107 | 661-669 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T108 | 786-794 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T109 | 795-804 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T110 | 1089-1100 | Disease | denotes | lymphopenia | http://purl.obolibrary.org/obo/MONDO_0003783 |
| T111 | 1228-1239 | Disease | denotes | lymphopenia | http://purl.obolibrary.org/obo/MONDO_0003783 |
| T112 | 1252-1260 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T113 | 1269-1277 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T161 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T162 | 192-196 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T163 | 192-196 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
| T164 | 287-293 | http://purl.obolibrary.org/obo/CLO_0053003 | denotes | 11, 25 |
| T165 | 506-511 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
| T166 | 587-591 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T167 | 587-591 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
| T168 | 641-645 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T169 | 641-645 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
| T170 | 687-688 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T171 | 921-925 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T172 | 921-925 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
| T173 | 981-983 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
| T174 | 1166-1168 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T36 | 1055-1079 | Phenotype | denotes | laboratory abnormalities | http://purl.obolibrary.org/obo/HP_0001939 |
| T37 | 1089-1100 | Phenotype | denotes | lymphopenia | http://purl.obolibrary.org/obo/HP_0001888 |
| T38 | 1144-1161 | Phenotype | denotes | immune deficiency | http://purl.obolibrary.org/obo/HP_0002721 |
| T39 | 1228-1239 | Phenotype | denotes | lymphopenia | http://purl.obolibrary.org/obo/HP_0001888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T293 | 0-101 | Sentence | denotes | A total of 1745 lesions were evaluated for the qualitative feature, location, and size in this study. |
| T294 | 102-295 | Sentence | denotes | Consistent with the previous studies, the ground-glass opacities and consolidation in the lung periphery were considered to be the imaging hallmark in patients with COVID-19 infection [11, 25]. |
| T295 | 296-439 | Sentence | denotes | However, when we subdivided the GGO into pure GGO and mixed GGO, we found that the distribution pattern is different between these two lesions. |
| T296 | 440-602 | Sentence | denotes | Pure GGO show differences between groups in every location of the lungs, whereas mixed GGO only have significant differences between groups in the lung periphery. |
| T297 | 603-675 | Sentence | denotes | Recent studies defined four stages of lung involvement in COVID-19 [26]. |
| T298 | 676-752 | Sentence | denotes | Therefore, a follow-up analysis of these distributions would be significant. |
| T299 | 753-841 | Sentence | denotes | The lesion size in patients with COVID-19 infection was another interesting observation. |
| T300 | 842-985 | Sentence | denotes | Most lesions were between 1 and 3 cm, with few lesions larger than half of the lung segment, which was similar to the finding in MERS_CoV [22]. |
| T301 | 986-1170 | Sentence | denotes | Other features similar to MERS_CoV and SARS_CoV were observed in the laboratory abnormalities, such as lymphopenia, which may be associated with the cellular immune deficiency [3, 27]. |
| T302 | 1171-1287 | Sentence | denotes | However, our results showed no significant difference in lymphopenia between the COVID-19 and non-COVID-19 patients. |